Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00028951 · ClinicalTrials.gov registry record · Phase 3
Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
A Phase 3 study, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00028951 is a Phase 3 study that has completed, run by Gynecologic Oncology Group.
The verdict
NCT00028951, a Phase 3 study, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Fibrin sealant may decrease lymphedema following surgery to remove lymph nodes in the groin by helping to seal the lymphatic vessels. It is not yet known if fibrin sealant is effective in decreasing lymphedema following surgery to remove lymph nodes. PURPOSE: Randomized phase III trial to determine the effectiveness of fibrin sealant in reducing lymphedema following surgical removal of lymph nodes in patients who have cancer of the vulva.
Interventions
- DRUG fibrin sealant
- PROCEDURE surgical wound closure
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00028951
The ClinicalTrials.gov registry entry for NCT00028951 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which fibrin sealant is the first listed.
NCT00028951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00028951 about?
NCT00028951 is a clinical study titled "Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva". RATIONALE: Fibrin sealant may decrease lymphedema following surgery to remove lymph nodes in the groin by helping to seal the lymphatic vessels. It is not yet known if fibrin sealant is effective in decreasing lymphedema following surgery to remove lymph nodes. PURPOSE: Randomized phase III trial t...
What is the current status of trial NCT00028951?
This trial is currently completed. It is a Phase 3 study. The study started on 2003-01.
What interventions are being tested in trial NCT00028951?
The interventions under investigation include: fibrin sealant (DRUG), surgical wound closure (PROCEDURE).
Who is sponsoring clinical trial NCT00028951?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.